Safety and Immunogenicity of an A (H1N1) 2009 Influenza Virus-like Particle (VLP) Vaccine

Clinical trial NCT01072799 · COMPLETED

Trial details

NCT number: NCT01072799
Sponsor: Novavax
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Seasonal Influenza

Start date: 2009-10-01
Primary completion: 2012-03-01
Enrollment: 4560

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.